| Title |
Has the DOTS Strategy Improved Case Finding or Treatment Success? An Empirical Assessment
|
|---|---|
| Published in |
PLOS ONE, March 2008
|
| DOI | 10.1371/journal.pone.0001721 |
| Pubmed ID | |
| Authors |
Ziad Obermeyer, Jesse Abbott-Klafter, Christopher J. L. Murray |
| Abstract |
Nearly fifteen years after the start of WHO's DOTS strategy, tuberculosis remains a major global health problem. Given the lack of empirical evidence that DOTS reduces tuberculosis burden, considerable debate has arisen about its place in the future of global tuberculosis control efforts. An independent evaluation of DOTS, one of the most widely-implemented and longest-running interventions in global health, is a prerequisite for meaningful improvements to tuberculosis control efforts, including WHO's new Stop TB Strategy. We investigate the impact of the expansion of the DOTS strategy on tuberculosis case finding and treatment success, using only empirical data. |
Mendeley readers
The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| South Africa | 3 | 2% |
| United Kingdom | 2 | 1% |
| Switzerland | 1 | <1% |
| India | 1 | <1% |
| Sweden | 1 | <1% |
| Sierra Leone | 1 | <1% |
| Tunisia | 1 | <1% |
| Denmark | 1 | <1% |
| Japan | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 170 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 48 | 26% |
| Researcher | 28 | 15% |
| Student > Ph. D. Student | 23 | 13% |
| Student > Postgraduate | 19 | 10% |
| Student > Bachelor | 11 | 6% |
| Other | 28 | 15% |
| Unknown | 26 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 38% |
| Agricultural and Biological Sciences | 18 | 10% |
| Social Sciences | 17 | 9% |
| Nursing and Health Professions | 15 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 25 | 14% |
| Unknown | 32 | 17% |